Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation

Eugenia Raichlin, Malik A. Al-Omari, Courtney L. Hayes, Brooks Sayre Edwards, Robert Frantz, Barry A. Boilson, Alfredo L. Clavell, Richard J. Rodeheffer, John A. Schirger, Sudhir S. Kushwaha, Thomas G. Allison, Naveen Luke Pereira

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Exercise performance, an important aspect of quality of life, remains limited after heart transplantation (HTx). This study examines the effect of cardiac allograft remodeling on functional capacity after HTx. Methods: The total cohort of 117 HTx recipients, based on echocardiographic determination of left ventricle mass and relative wall thickness at 1 year after HTx, was divided into 3 groups: (1) NG, normal geometry; (2) CR, concentric remodeling; and (3) CH, concentric hypertrophy. Cardiopulmonary exercise testing was performed 5.03 ± 3.08 years after HTx in all patients. Patients with acute rejection or significant graft vasculopathy were excluded. Results: At 1 year post-HTx, 30% of patients had CH, 55% had CR and 15% had NG. Exercise tolerance, measured by maximum achieved metabolic equivalents (4.62 ± 1.44 vs 5.52 ± 0.96 kcal/kg/h), normalized peak Vo 2 (52 ± 14% vs 63 ± 12%) and Ve/Vco 2 (41 ± 17 vs 34 ± 6), was impaired in the CH group compared with the NG group. A peak Vo 2 ≤14 ml/kg/min was found in 6%, 22% and 48% of patients in the NG, CR and CH groups, respectively (p = 0.01). The CH pattern was associated with a 7.4-fold increase in relative risk for a peak Vo 2 ≤14 ml/kg/min compared with NG patients (95% confidence interval 1.1 to 51.9, p = 0.001). After multivariate analysis, a 1-year CH pattern was independently associated with a reduced normalized peak Vo 2 (p = 0.018) and an elevated Ve/Vco 2 (p = 0.035). Conclusions: The presence of CH at 1 year after HTx is independently associated with decreased normalized peak Vo 2 and increased ventilatory response in stable heart transplant recipients. The identification of CH, a potentially reversible mechanism of impairment in exercise capacity after HTx, may have major clinical implications.

Original languageEnglish (US)
Pages (from-to)1153-1160
Number of pages8
JournalJournal of Heart and Lung Transplantation
Volume30
Issue number10
DOIs
StatePublished - Oct 2011

Fingerprint

Exercise Tolerance
Cardiomegaly
Heart Transplantation
Allografts
Exercise
Metabolic Equivalent
Hypertrophy
Heart Ventricles
Multivariate Analysis
Quality of Life
Confidence Intervals
Transplants

Keywords

  • cardiac allograft remodeling
  • exercise intolerance
  • exercise physiology
  • heart transplantation
  • left ventricular hypertrophy

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. / Raichlin, Eugenia; Al-Omari, Malik A.; Hayes, Courtney L.; Edwards, Brooks Sayre; Frantz, Robert; Boilson, Barry A.; Clavell, Alfredo L.; Rodeheffer, Richard J.; Schirger, John A.; Kushwaha, Sudhir S.; Allison, Thomas G.; Pereira, Naveen Luke.

In: Journal of Heart and Lung Transplantation, Vol. 30, No. 10, 10.2011, p. 1153-1160.

Research output: Contribution to journalArticle

Raichlin, E, Al-Omari, MA, Hayes, CL, Edwards, BS, Frantz, R, Boilson, BA, Clavell, AL, Rodeheffer, RJ, Schirger, JA, Kushwaha, SS, Allison, TG & Pereira, NL 2011, 'Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation', Journal of Heart and Lung Transplantation, vol. 30, no. 10, pp. 1153-1160. https://doi.org/10.1016/j.healun.2011.04.012
Raichlin, Eugenia ; Al-Omari, Malik A. ; Hayes, Courtney L. ; Edwards, Brooks Sayre ; Frantz, Robert ; Boilson, Barry A. ; Clavell, Alfredo L. ; Rodeheffer, Richard J. ; Schirger, John A. ; Kushwaha, Sudhir S. ; Allison, Thomas G. ; Pereira, Naveen Luke. / Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. In: Journal of Heart and Lung Transplantation. 2011 ; Vol. 30, No. 10. pp. 1153-1160.
@article{3fe9b1c7977c4808a7c7662814b476c3,
title = "Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation",
abstract = "Background: Exercise performance, an important aspect of quality of life, remains limited after heart transplantation (HTx). This study examines the effect of cardiac allograft remodeling on functional capacity after HTx. Methods: The total cohort of 117 HTx recipients, based on echocardiographic determination of left ventricle mass and relative wall thickness at 1 year after HTx, was divided into 3 groups: (1) NG, normal geometry; (2) CR, concentric remodeling; and (3) CH, concentric hypertrophy. Cardiopulmonary exercise testing was performed 5.03 ± 3.08 years after HTx in all patients. Patients with acute rejection or significant graft vasculopathy were excluded. Results: At 1 year post-HTx, 30{\%} of patients had CH, 55{\%} had CR and 15{\%} had NG. Exercise tolerance, measured by maximum achieved metabolic equivalents (4.62 ± 1.44 vs 5.52 ± 0.96 kcal/kg/h), normalized peak Vo 2 (52 ± 14{\%} vs 63 ± 12{\%}) and Ve/Vco 2 (41 ± 17 vs 34 ± 6), was impaired in the CH group compared with the NG group. A peak Vo 2 ≤14 ml/kg/min was found in 6{\%}, 22{\%} and 48{\%} of patients in the NG, CR and CH groups, respectively (p = 0.01). The CH pattern was associated with a 7.4-fold increase in relative risk for a peak Vo 2 ≤14 ml/kg/min compared with NG patients (95{\%} confidence interval 1.1 to 51.9, p = 0.001). After multivariate analysis, a 1-year CH pattern was independently associated with a reduced normalized peak Vo 2 (p = 0.018) and an elevated Ve/Vco 2 (p = 0.035). Conclusions: The presence of CH at 1 year after HTx is independently associated with decreased normalized peak Vo 2 and increased ventilatory response in stable heart transplant recipients. The identification of CH, a potentially reversible mechanism of impairment in exercise capacity after HTx, may have major clinical implications.",
keywords = "cardiac allograft remodeling, exercise intolerance, exercise physiology, heart transplantation, left ventricular hypertrophy",
author = "Eugenia Raichlin and Al-Omari, {Malik A.} and Hayes, {Courtney L.} and Edwards, {Brooks Sayre} and Robert Frantz and Boilson, {Barry A.} and Clavell, {Alfredo L.} and Rodeheffer, {Richard J.} and Schirger, {John A.} and Kushwaha, {Sudhir S.} and Allison, {Thomas G.} and Pereira, {Naveen Luke}",
year = "2011",
month = "10",
doi = "10.1016/j.healun.2011.04.012",
language = "English (US)",
volume = "30",
pages = "1153--1160",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation

AU - Raichlin, Eugenia

AU - Al-Omari, Malik A.

AU - Hayes, Courtney L.

AU - Edwards, Brooks Sayre

AU - Frantz, Robert

AU - Boilson, Barry A.

AU - Clavell, Alfredo L.

AU - Rodeheffer, Richard J.

AU - Schirger, John A.

AU - Kushwaha, Sudhir S.

AU - Allison, Thomas G.

AU - Pereira, Naveen Luke

PY - 2011/10

Y1 - 2011/10

N2 - Background: Exercise performance, an important aspect of quality of life, remains limited after heart transplantation (HTx). This study examines the effect of cardiac allograft remodeling on functional capacity after HTx. Methods: The total cohort of 117 HTx recipients, based on echocardiographic determination of left ventricle mass and relative wall thickness at 1 year after HTx, was divided into 3 groups: (1) NG, normal geometry; (2) CR, concentric remodeling; and (3) CH, concentric hypertrophy. Cardiopulmonary exercise testing was performed 5.03 ± 3.08 years after HTx in all patients. Patients with acute rejection or significant graft vasculopathy were excluded. Results: At 1 year post-HTx, 30% of patients had CH, 55% had CR and 15% had NG. Exercise tolerance, measured by maximum achieved metabolic equivalents (4.62 ± 1.44 vs 5.52 ± 0.96 kcal/kg/h), normalized peak Vo 2 (52 ± 14% vs 63 ± 12%) and Ve/Vco 2 (41 ± 17 vs 34 ± 6), was impaired in the CH group compared with the NG group. A peak Vo 2 ≤14 ml/kg/min was found in 6%, 22% and 48% of patients in the NG, CR and CH groups, respectively (p = 0.01). The CH pattern was associated with a 7.4-fold increase in relative risk for a peak Vo 2 ≤14 ml/kg/min compared with NG patients (95% confidence interval 1.1 to 51.9, p = 0.001). After multivariate analysis, a 1-year CH pattern was independently associated with a reduced normalized peak Vo 2 (p = 0.018) and an elevated Ve/Vco 2 (p = 0.035). Conclusions: The presence of CH at 1 year after HTx is independently associated with decreased normalized peak Vo 2 and increased ventilatory response in stable heart transplant recipients. The identification of CH, a potentially reversible mechanism of impairment in exercise capacity after HTx, may have major clinical implications.

AB - Background: Exercise performance, an important aspect of quality of life, remains limited after heart transplantation (HTx). This study examines the effect of cardiac allograft remodeling on functional capacity after HTx. Methods: The total cohort of 117 HTx recipients, based on echocardiographic determination of left ventricle mass and relative wall thickness at 1 year after HTx, was divided into 3 groups: (1) NG, normal geometry; (2) CR, concentric remodeling; and (3) CH, concentric hypertrophy. Cardiopulmonary exercise testing was performed 5.03 ± 3.08 years after HTx in all patients. Patients with acute rejection or significant graft vasculopathy were excluded. Results: At 1 year post-HTx, 30% of patients had CH, 55% had CR and 15% had NG. Exercise tolerance, measured by maximum achieved metabolic equivalents (4.62 ± 1.44 vs 5.52 ± 0.96 kcal/kg/h), normalized peak Vo 2 (52 ± 14% vs 63 ± 12%) and Ve/Vco 2 (41 ± 17 vs 34 ± 6), was impaired in the CH group compared with the NG group. A peak Vo 2 ≤14 ml/kg/min was found in 6%, 22% and 48% of patients in the NG, CR and CH groups, respectively (p = 0.01). The CH pattern was associated with a 7.4-fold increase in relative risk for a peak Vo 2 ≤14 ml/kg/min compared with NG patients (95% confidence interval 1.1 to 51.9, p = 0.001). After multivariate analysis, a 1-year CH pattern was independently associated with a reduced normalized peak Vo 2 (p = 0.018) and an elevated Ve/Vco 2 (p = 0.035). Conclusions: The presence of CH at 1 year after HTx is independently associated with decreased normalized peak Vo 2 and increased ventilatory response in stable heart transplant recipients. The identification of CH, a potentially reversible mechanism of impairment in exercise capacity after HTx, may have major clinical implications.

KW - cardiac allograft remodeling

KW - exercise intolerance

KW - exercise physiology

KW - heart transplantation

KW - left ventricular hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=80053328575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053328575&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2011.04.012

DO - 10.1016/j.healun.2011.04.012

M3 - Article

C2 - 21621424

AN - SCOPUS:80053328575

VL - 30

SP - 1153

EP - 1160

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 10

ER -